These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 11895127

  • 1. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
    Tabner BJ, Turnbull S, El-Agnaf O, Allsop D.
    Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
    [Abstract] [Full Text] [Related]

  • 2. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
    Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D.
    Free Radic Biol Med; 2002 Jun 01; 32(11):1076-83. PubMed ID: 12031892
    [Abstract] [Full Text] [Related]

  • 3. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
    Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D.
    Free Radic Biol Med; 2001 May 15; 30(10):1163-70. PubMed ID: 11369507
    [Abstract] [Full Text] [Related]

  • 4. A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein.
    Tabner BJ, Turnbull S, King JE, Benson FE, El-Agnaf OM, Allsop D.
    Free Radic Res; 2006 Jul 15; 40(7):731-9. PubMed ID: 16984000
    [Abstract] [Full Text] [Related]

  • 5. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M, Rockenstein E, Crews L, Masliah E.
    Neuromolecular Med; 2003 Jul 15; 4(1-2):21-36. PubMed ID: 14528050
    [Abstract] [Full Text] [Related]

  • 6. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 7. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA, Jäkälä P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K.
    Neurosci Lett; 1999 May 14; 266(3):213-6. PubMed ID: 10465711
    [Abstract] [Full Text] [Related]

  • 8. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.
    Walsh DM, Selkoe DJ.
    Protein Pept Lett; 2004 Jun 14; 11(3):213-28. PubMed ID: 15182223
    [Abstract] [Full Text] [Related]

  • 9. In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.
    Lashuel HA, Grillo-Bosch D.
    Methods Mol Biol; 2005 Jun 14; 299():19-33. PubMed ID: 15980593
    [Abstract] [Full Text] [Related]

  • 10. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease.
    Li J, Zhu M, Manning-Bog AB, Di Monte DA, Fink AL.
    FASEB J; 2004 Jun 14; 18(9):962-4. PubMed ID: 15059976
    [Abstract] [Full Text] [Related]

  • 11. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L.
    Proc Natl Acad Sci U S A; 2001 Oct 09; 98(21):12245-50. PubMed ID: 11572944
    [Abstract] [Full Text] [Related]

  • 12. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A.
    Biochim Biophys Acta; 2000 Jul 26; 1502(1):95-109. PubMed ID: 10899435
    [Abstract] [Full Text] [Related]

  • 13. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ.
    Glycobiology; 2005 Dec 26; 15(12):1320-31. PubMed ID: 16037493
    [Abstract] [Full Text] [Related]

  • 14. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR, Shin HJ, Lee JH, Chang CS, Kim J.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [Abstract] [Full Text] [Related]

  • 15. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
    Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten H.
    Neuropharmacology; 2003 Jul 15; 45(1):14-44. PubMed ID: 12814657
    [Abstract] [Full Text] [Related]

  • 16. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
    Bodles AM, Guthrie DJ, Harriott P, Campbell P, Irvine GB.
    Eur J Biochem; 2000 Apr 15; 267(8):2186-94. PubMed ID: 10759841
    [Abstract] [Full Text] [Related]

  • 17. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K, Vondrakova D, Lawson M, Valko M.
    Mol Cell Biochem; 2010 Dec 15; 345(1-2):91-104. PubMed ID: 20730621
    [Abstract] [Full Text] [Related]

  • 18. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
    Foguel D, Suarez MC, Ferrão-Gonzales AD, Porto TC, Palmieri L, Einsiedler CM, Andrade LR, Lashuel HA, Lansbury PT, Kelly JW, Silva JL.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9831-6. PubMed ID: 12900507
    [Abstract] [Full Text] [Related]

  • 19. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y, Miller Y.
    ACS Chem Neurosci; 2016 Jan 20; 7(1):46-55. PubMed ID: 26479553
    [Abstract] [Full Text] [Related]

  • 20. Alpha-synuclein and the pathogenesis of Parkinson's disease.
    Martin FL, Williamson SJ, Paleologou KE, Allsop D, El-Agnaf OM.
    Protein Pept Lett; 2004 Jun 20; 11(3):229-37. PubMed ID: 15182224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.